Cita APA

Koyanagi, T., Saga, Y., Takahashi, Y., Tamura, K., Yoshiba, T., Takahashi, S., . . . Fujiwara, H. (2021). Knockout of vasohibin‐2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer. Cancer Med.

Chicago Style Citation

Koyanagi, Takahiro, et al. "Knockout of Vasohibin‐2 Reduces Tubulin Carboxypeptidase Activity and Increases Paclitaxel Sensitivity in Ovarian Cancer." Cancer Med 2021.

Cita MLA

Koyanagi, Takahiro, et al. "Knockout of Vasohibin‐2 Reduces Tubulin Carboxypeptidase Activity and Increases Paclitaxel Sensitivity in Ovarian Cancer." Cancer Med 2021.